The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway

The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway

The identification of cancer-associated mutations in the tricarboxylic acid (TCA) cycle enzymes isocitrate dehydrogenases 1 and 2 (IDH1/2) highlights the prevailing notion that aberrant metabolic function can contribute to carcinogenesis. IDH1/2 normally catalyse the oxidative decarboxylation of iso...

書誌詳細
主要な著者:	Carbonneau, M, M Gagné, L, Lalonde, M, Germain, M, Motorina, A, Guiot, M, Secco, B, Vincent, E, Tumber, A, Hulea, L, Bergeman, J, Oppermann, U, Jones, R, Laplante, M, Topisirovic, I, Petrecca, K, Huot, M, Mallette, F
フォーマット:	Journal article
言語:	English
出版事項:	Springer Nature 2016

類似資料

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.
著者:: Chowdhury, R, 等
出版事項: (2011)

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
著者:: Chowdhury, R, 等
出版事項: (2011)

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
著者:: Chowdhury, R, 等
出版事項: (2011)

Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d-2-Hydroxyglutarate
著者:: Teng, Xin, 等
出版事項: (2016)

Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity
著者:: Mengyuan Cai, 等
出版事項: (2024-01-01)

Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate
著者:: Lorenzo Galluzzi, 等
出版事項: (2018-12-01)

The Enzymology of 2-Hydroxyglutarate, 2-Hydroxyglutaramate and 2-Hydroxysuccinamate and Their Relationship to Oncometabolites
著者:: Vivek A. Hariharan, 等
出版事項: (2017-03-01)

Focused screening identifies different sensitivities of human TET oxygenases to the oncometabolite 2-hydroxyglutarate
著者:: Belle, R, 等
出版事項: (2024)

Registered report: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases
著者:: Brad Evans, 等
出版事項: (2015-07-01)

Oncometabolites D- and L-2-hydroxyglutarate Inhibit the AlkB Family DNA Repair Enzymes under Physiological Conditions
著者:: Chen, Fangyi, 等
出版事項: (2018)

Oncometabolite D-2-hydroxyglutarate—dependent metabolic reprogramming induces skeletal muscle atrophy during cancer cachexia
著者:: Xinting Zhu, 等
出版事項: (2023-09-01)

mTOR Signaling in Growth Control and Disease
著者:: Laplante, Mathieu, 等
出版事項: (2014)

Intracerebral Distribution of the Oncometabolite D-2-Hydroxyglutarate in Mice Bearing Mutant Isocitrate Dehydrogenase Brain Tumors: Implications for Tumorigenesis
著者:: Amanda Pickard, 等
出版事項: (2016-10-01)

Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiation
著者:: Mary Taub, 等
出版事項: (2022-09-01)

Oncometabolite D-2-Hydroxyglutarate enhances gene silencing through inhibition of specific H3K36 histone demethylases
著者:: Ryan Janke, 等
出版事項: (2017-03-01)

The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
著者:: Luyan Mu, 等
出版事項: (2018-03-01)

An emerging role of mTOR in lipid biosynthesis
著者:: Laplante, Mathieu, 等
出版事項: (2012)

Accumulation of oncometabolite D-2-Hydroxyglutarate by SLC25A1 inhibition: A metabolic strategy for induction of HR-ness and radiosensitivity
著者:: Kexu Xiang, 等
出版事項: (2022-07-01)

The emerging role of fumarate as an oncometabolite.
著者:: Yang, M, 等
出版事項: (2012)

Oncometabolites: linking altered metabolism with cancer.
著者:: Yang, M, 等
出版事項: (2013)

Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.
著者:: Luyuan Li, 等
出版事項: (2015-01-01)

The Emerging Role of LPA as an Oncometabolite
著者:: Theodoros Karalis, 等
出版事項: (2024-04-01)

The emerging role of fumarate as an oncometabolite
著者:: Ming eYang, 等
出版事項: (2012-07-01)

Hydroxyglutaric Acidemia
著者:: J Gordon Millichap
出版事項: (1992-09-01)

Targeting mTOR in Acute Lymphoblastic Leukemia
著者:: Carolina Simioni, 等
出版事項: (2019-02-01)

Oncometabolites: A new insight for oncology
著者:: Fatemeh Khatami, 等
出版事項: (2019-09-01)

Autism and Hydroxyglutaric Aciduria
著者:: J Gordon Millichap
出版事項: (2008-04-01)

The Roles of 2-Hydroxyglutarate
著者:: Xin Du, 等
出版事項: (2021-03-01)

DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
著者:: Peterson, Timothy R., 等
出版事項: (2015)

AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1
著者:: George K. E. Umanah, 等
出版事項: (2022-08-01)

Dietary protein sources differentially affect microbiota, mTOR activity and transcription of mTOR signaling pathways in the small intestine.
著者:: Soumya K Kar, 等
出版事項: (2017-01-01)

mTOR at the nexus of nutrition, growth, ageing and disease
著者:: Liu, Grace Y, 等
出版事項: (2021)

MTOR modulation induces selective perturbations in histone methylation which influence the anti-proliferative effects of mTOR inhibitors
著者:: Kim, HaEun, 等
出版事項: (2024)

MTOR modulation induces selective perturbations in histone methylation which influence the anti-proliferative effects of mTOR inhibitors
著者:: HaEun Kim, 等
出版事項: (2024-03-01)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
著者:: Victor H. Villar, 等
出版事項: (2017-05-01)

Oncometabolite induced primary cilia loss in pheochromocytoma
著者:: O'Toole, SM, 等
出版事項: (2019)

mTOR at the Transmitting and Receiving Ends in Tumor Immunity
著者:: Yakir Guri, 等
出版事項: (2018-03-01)

mTOR, autophagy and reprogramming
著者:: Bor Luen eTang
出版事項: (2014-01-01)

A Central Role for mTOR in Lipid Homeostasis
著者:: Lamming, Dudley W., 等
出版事項: (2016)

The role of the mTor pathway for the development of the mouse thymic epithelium and function
著者:: Berkemeier, C, 等
出版事項: (2010)